Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alexander's

201.85
+3.001.51%
Post-market: 201.850.00000.00%19:56 EDT
Volume:9.77K
Turnover:1.96M
Market Cap:1.03B
PE:23.86
High:202.50
Open:199.53
Low:199.53
Close:198.85
Loading ...

ALX Oncology Highlights Promising Trial Results

TIPRANKS
·
09 Nov 2024

ALX Oncology Holdings Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58) Beats $(0.79) Estimate

Benzinga
·
08 Nov 2024

BRIEF-ALX Oncology Q3 Basic EPS USD -0.58

Reuters
·
08 Nov 2024

ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
08 Nov 2024

Alexander's Inc (ALX) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

GuruFocus.com
·
06 Nov 2024

Alexander's Q3 Adjusted FFO Falls, Revenue Rises

MT Newswires Live
·
04 Nov 2024

BRIEF-Alexander's Q3 Adjusted FFO Per Share USD 2.84

Reuters
·
04 Nov 2024

Alexander's Q3 Adjusted Ffo USD 14.582 Million

THOMSON REUTERS
·
04 Nov 2024

Alexander’s Announces Third Quarter Financial Results

GlobeNewswire
·
04 Nov 2024

Alexander's Q3 FFO $2.84 Beats $2.57 Estimate, Sales $55.67M Beat $53.50M Estimate

Benzinga
·
04 Nov 2024

Alexander's: Q3 Earnings Snapshot

Associated Press Finance
·
04 Nov 2024

ALX Oncology Announces November Investor Conference Participation

GlobeNewswire
·
04 Nov 2024

ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024

GlobeNewswire
·
02 Nov 2024

Alexander's Inc expected to post a share - Earnings Preview

Reuters
·
01 Nov 2024

Alexander's Keeps Quarterly Dividend at $4.50 a Share, Payable Nov. 29 to Shareholders of Record Nov. 11

MT Newswires Live
·
31 Oct 2024

Alexander’s Declares Quarterly $4.50 Dividend on Common Shares

GlobeNewswire
·
31 Oct 2024